Eloro Resources Increases Financing
TORONTO, Jan. 25, 2019 (GLOBE NEWSWIRE) — Eloro Resources Ltd. (TSX-V: ELO; FSE: P2Q) (“Eloro” or the “Corporation”) is pleased […]
Monolithic Power Systems to Report Fourth Quarter and Full Year Results on February 12, 2019
Kirkland, Wash., Jan. 25, 2019 (GLOBE NEWSWIRE) — Monolithic Power Systems (MPS) (Nasdaq: MPWR), a leading company in high performance […]
Stifel Financial Schedules Fourth Quarter & Full Year 2018 Financial Results Conference Call
ST. LOUIS, Jan. 25, 2019 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full […]
Mueller Water Products Announces Quarterly Dividend
ATLANTA, Jan. 25, 2019 (GLOBE NEWSWIRE) — Mueller Water Products, Inc. (NYSE: MWA) announced that its Board of Directors has […]
Valero Energy Corporation Will Attend the Simmons Energy Conference
SAN ANTONIO, Jan. 25, 2019 (GLOBE NEWSWIRE) — Valero Energy Corporation (NYSE: VLO) (“Valero”) today announced that members of company […]
Dynagas LNG Partners Announces Reduction in Quarterly Distribution to $0.0625 Per Common Unit for the Fourth Quarter 2018
MONACO, Jan. 25, 2019 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (the “Partnership”) (NYSE: DLNG), an owner and operator of […]
New York Stock Exchange Accepts Milestone Scientific’s Plan to Regain Compliance
LIVINGSTON, N.J., Jan. 25, 2019 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery […]
Domo Named to G2 Crowd’s Best Software Companies 2019
SILICON SLOPES, Utah, Jan. 25, 2019 (GLOBE NEWSWIRE) — Domo® (Nasdaq: DOMO), provider of the leading cloud-based operating system for business, […]
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date January 15, 2019
NEW YORK, Jan. 25, 2019 (GLOBE NEWSWIRE) — At the end of the settlement date of January 15, 2019, short […]
Bellerophon Announces Closing of $7 Million Public Offering of Common Stock
WARREN, N.J., Jan. 25, 2019 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics […]
